Surgical Innovations expands in US

The Leeds-based firm said the Logic instruments were compatible with its Logic Handles, which already have approval in the US, and are currently used with its Resposable Logi range.

Chief executive Graham Bowland said: “We are delighted to announce the FDA approval of our reusable instruments in the US. The economic drivers away from single use instruments in the US are clear, and our modular instruments are ideally positioned to satisfy current surgical procedure budgets.”

In addition, the group’s main US dealer, SI USA, has been awarded a contract by the Premier healthcare alliance for the sale of both the Resposable Logi range, and Logic range. The contract will run from April 1 2012 for three years, with the option to extend a further two years.

The contract will provide Surgical Innovations with additional access to hospitals and hospital networks across the US, and replaces previous, but more limited, contracts already held with Premier.

Mr Bowland added: “This latest contract with Premier provides us with much more flexibility in the products we can offer whilst giving us access to hospitals that we were previously unable to approach. This is a very exciting development for the group and strengthens our position in our largest target market.”